Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats

Nader D. Nader, Paul R. Knight, Bruce A. Davidson, Saeid S. Safaee, David M. Steinhorn

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Perflurocarbons (PFCs) are used during liquid ventilation and as hemoglobin substitutes. PFCs reduce free radical generation and damage to the lung during liquid ventilation. Thus, we examined the effects of parenteral administration of PFCs on lung injury after acid aspiration. Rats were treated with intraperitoneal injection of either FC-77 or IV injection of Fluosol. Controls received intraperitoneal or IV normal saline (NS) before or at the time of injury and then were injured by instillation of NS + HCl (pH = 1.25) into their lungs via a tracheotomy. The animals were exposed to air or 98% oxygen, breathing spontaneously. The rats were injected with 0.05 μCi of 125I-albumin (bovine serum albumin) before injury. The extent of lung injury was assessed 5 h postinjury by compliance and lung albumin permeability index measurement. Myeloperoxidase (MPO) activity and histologic examination were used to assess neutrophilic infiltration. Both FC-77 and Fluosol decreased the permeability index compared with controls (1.05 ± 0.08; 1.08 ± 0.12, respectively, versus 1.34 ± 0.21) and improved lung compliance after intratracheal instillation of 1.2 mL/kg of HCl/NS, pH = 1.25 + hyperoxia injury (P < 0.05). Lung MPO activity decreased in the FC-77 group and was associated with a concomitant decrease in neutrophil infiltration. MPO activity of the spleen increased after FC-77 treatment. The administration of FC-77 decreased the severity of lung permeability changes associated with acid in the presence or absence of hyperoxia exposure. These data suggest that attenuation of neutrophilic infiltration by PFCs decreases lung injury. Implications: Intraperitoneally administered perfluorocarbons in rats attenuate the neutrophilic infiltration in the lung after acid aspiration, thereby decreasing the alveolar protein leakage and improving pulmonary compliance.

Original languageEnglish (US)
Pages (from-to)356-361
Number of pages6
JournalAnesthesia and Analgesia
Volume90
Issue number2
StatePublished - 2000
Externally publishedYes

Fingerprint

Fluorocarbons
Gastric Acid
Pneumonia
Lung Compliance
Lung Injury
Lung
Liquid Ventilation
Peroxidase
Permeability
Hyperoxia
Acids
Albumins
Wounds and Injuries
Blood Substitutes
Tracheotomy
Neutrophil Infiltration
Bovine Serum Albumin
Intraperitoneal Injections
Free Radicals
Respiration

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Nader, N. D., Knight, P. R., Davidson, B. A., Safaee, S. S., & Steinhorn, D. M. (2000). Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats. Anesthesia and Analgesia, 90(2), 356-361.

Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats. / Nader, Nader D.; Knight, Paul R.; Davidson, Bruce A.; Safaee, Saeid S.; Steinhorn, David M.

In: Anesthesia and Analgesia, Vol. 90, No. 2, 2000, p. 356-361.

Research output: Contribution to journalArticle

Nader, ND, Knight, PR, Davidson, BA, Safaee, SS & Steinhorn, DM 2000, 'Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats', Anesthesia and Analgesia, vol. 90, no. 2, pp. 356-361.
Nader, Nader D. ; Knight, Paul R. ; Davidson, Bruce A. ; Safaee, Saeid S. ; Steinhorn, David M. / Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats. In: Anesthesia and Analgesia. 2000 ; Vol. 90, No. 2. pp. 356-361.
@article{8553c56a335344f2ab439b9ec5e087fd,
title = "Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats",
abstract = "Perflurocarbons (PFCs) are used during liquid ventilation and as hemoglobin substitutes. PFCs reduce free radical generation and damage to the lung during liquid ventilation. Thus, we examined the effects of parenteral administration of PFCs on lung injury after acid aspiration. Rats were treated with intraperitoneal injection of either FC-77 or IV injection of Fluosol. Controls received intraperitoneal or IV normal saline (NS) before or at the time of injury and then were injured by instillation of NS + HCl (pH = 1.25) into their lungs via a tracheotomy. The animals were exposed to air or 98{\%} oxygen, breathing spontaneously. The rats were injected with 0.05 μCi of 125I-albumin (bovine serum albumin) before injury. The extent of lung injury was assessed 5 h postinjury by compliance and lung albumin permeability index measurement. Myeloperoxidase (MPO) activity and histologic examination were used to assess neutrophilic infiltration. Both FC-77 and Fluosol decreased the permeability index compared with controls (1.05 ± 0.08; 1.08 ± 0.12, respectively, versus 1.34 ± 0.21) and improved lung compliance after intratracheal instillation of 1.2 mL/kg of HCl/NS, pH = 1.25 + hyperoxia injury (P < 0.05). Lung MPO activity decreased in the FC-77 group and was associated with a concomitant decrease in neutrophil infiltration. MPO activity of the spleen increased after FC-77 treatment. The administration of FC-77 decreased the severity of lung permeability changes associated with acid in the presence or absence of hyperoxia exposure. These data suggest that attenuation of neutrophilic infiltration by PFCs decreases lung injury. Implications: Intraperitoneally administered perfluorocarbons in rats attenuate the neutrophilic infiltration in the lung after acid aspiration, thereby decreasing the alveolar protein leakage and improving pulmonary compliance.",
author = "Nader, {Nader D.} and Knight, {Paul R.} and Davidson, {Bruce A.} and Safaee, {Saeid S.} and Steinhorn, {David M.}",
year = "2000",
language = "English (US)",
volume = "90",
pages = "356--361",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats

AU - Nader, Nader D.

AU - Knight, Paul R.

AU - Davidson, Bruce A.

AU - Safaee, Saeid S.

AU - Steinhorn, David M.

PY - 2000

Y1 - 2000

N2 - Perflurocarbons (PFCs) are used during liquid ventilation and as hemoglobin substitutes. PFCs reduce free radical generation and damage to the lung during liquid ventilation. Thus, we examined the effects of parenteral administration of PFCs on lung injury after acid aspiration. Rats were treated with intraperitoneal injection of either FC-77 or IV injection of Fluosol. Controls received intraperitoneal or IV normal saline (NS) before or at the time of injury and then were injured by instillation of NS + HCl (pH = 1.25) into their lungs via a tracheotomy. The animals were exposed to air or 98% oxygen, breathing spontaneously. The rats were injected with 0.05 μCi of 125I-albumin (bovine serum albumin) before injury. The extent of lung injury was assessed 5 h postinjury by compliance and lung albumin permeability index measurement. Myeloperoxidase (MPO) activity and histologic examination were used to assess neutrophilic infiltration. Both FC-77 and Fluosol decreased the permeability index compared with controls (1.05 ± 0.08; 1.08 ± 0.12, respectively, versus 1.34 ± 0.21) and improved lung compliance after intratracheal instillation of 1.2 mL/kg of HCl/NS, pH = 1.25 + hyperoxia injury (P < 0.05). Lung MPO activity decreased in the FC-77 group and was associated with a concomitant decrease in neutrophil infiltration. MPO activity of the spleen increased after FC-77 treatment. The administration of FC-77 decreased the severity of lung permeability changes associated with acid in the presence or absence of hyperoxia exposure. These data suggest that attenuation of neutrophilic infiltration by PFCs decreases lung injury. Implications: Intraperitoneally administered perfluorocarbons in rats attenuate the neutrophilic infiltration in the lung after acid aspiration, thereby decreasing the alveolar protein leakage and improving pulmonary compliance.

AB - Perflurocarbons (PFCs) are used during liquid ventilation and as hemoglobin substitutes. PFCs reduce free radical generation and damage to the lung during liquid ventilation. Thus, we examined the effects of parenteral administration of PFCs on lung injury after acid aspiration. Rats were treated with intraperitoneal injection of either FC-77 or IV injection of Fluosol. Controls received intraperitoneal or IV normal saline (NS) before or at the time of injury and then were injured by instillation of NS + HCl (pH = 1.25) into their lungs via a tracheotomy. The animals were exposed to air or 98% oxygen, breathing spontaneously. The rats were injected with 0.05 μCi of 125I-albumin (bovine serum albumin) before injury. The extent of lung injury was assessed 5 h postinjury by compliance and lung albumin permeability index measurement. Myeloperoxidase (MPO) activity and histologic examination were used to assess neutrophilic infiltration. Both FC-77 and Fluosol decreased the permeability index compared with controls (1.05 ± 0.08; 1.08 ± 0.12, respectively, versus 1.34 ± 0.21) and improved lung compliance after intratracheal instillation of 1.2 mL/kg of HCl/NS, pH = 1.25 + hyperoxia injury (P < 0.05). Lung MPO activity decreased in the FC-77 group and was associated with a concomitant decrease in neutrophil infiltration. MPO activity of the spleen increased after FC-77 treatment. The administration of FC-77 decreased the severity of lung permeability changes associated with acid in the presence or absence of hyperoxia exposure. These data suggest that attenuation of neutrophilic infiltration by PFCs decreases lung injury. Implications: Intraperitoneally administered perfluorocarbons in rats attenuate the neutrophilic infiltration in the lung after acid aspiration, thereby decreasing the alveolar protein leakage and improving pulmonary compliance.

UR - http://www.scopus.com/inward/record.url?scp=0033967173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033967173&partnerID=8YFLogxK

M3 - Article

C2 - 10648321

AN - SCOPUS:0033967173

VL - 90

SP - 356

EP - 361

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -